| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | G8 | 4.37e-05 | 4 | 51 | 2 | PF10162 | |
| Domain | G8_domain | 4.37e-05 | 4 | 51 | 2 | IPR019316 | |
| Domain | G8 | 4.37e-05 | 4 | 51 | 2 | PS51484 | |
| Domain | G8 | 4.37e-05 | 4 | 51 | 2 | SM01225 | |
| Domain | IPT | 5.36e-05 | 27 | 51 | 3 | SM00429 | |
| Domain | VWC | 5.99e-05 | 28 | 51 | 3 | PF00093 | |
| Domain | TIG | 8.17e-05 | 31 | 51 | 3 | PF01833 | |
| Domain | IPT | 9.00e-05 | 32 | 51 | 3 | IPR002909 | |
| Domain | PbH1 | 1.09e-04 | 6 | 51 | 2 | SM00710 | |
| Domain | PbH1 | 1.09e-04 | 6 | 51 | 2 | IPR006626 | |
| Domain | VWFC_1 | 1.29e-04 | 36 | 51 | 3 | PS01208 | |
| Domain | VWC | 1.51e-04 | 38 | 51 | 3 | SM00214 | |
| Domain | VWFC_2 | 1.51e-04 | 38 | 51 | 3 | PS50184 | |
| Domain | Ig_E-set | 1.85e-04 | 104 | 51 | 4 | IPR014756 | |
| Domain | Pectin_lyase_fold/virulence | 2.03e-04 | 8 | 51 | 2 | IPR011050 | |
| Domain | VWF_dom | 2.04e-04 | 42 | 51 | 3 | IPR001007 | |
| Domain | Peptidase_M14 | 1.78e-03 | 23 | 51 | 2 | PF00246 | |
| Domain | Peptidase_M14 | 1.78e-03 | 23 | 51 | 2 | IPR000834 | |
| Domain | - | 2.22e-03 | 95 | 51 | 3 | 2.60.120.200 | |
| Domain | Serpin_CS | 3.44e-03 | 32 | 51 | 2 | IPR023795 | |
| Domain | Serpin_dom | 4.34e-03 | 36 | 51 | 2 | IPR023796 | |
| Domain | SERPIN | 4.58e-03 | 37 | 51 | 2 | SM00093 | |
| Domain | SERPIN | 4.58e-03 | 37 | 51 | 2 | PS00284 | |
| Domain | Serpin | 4.83e-03 | 38 | 51 | 2 | PF00079 | |
| Domain | LAM_G_DOMAIN | 4.83e-03 | 38 | 51 | 2 | PS50025 | |
| Domain | Serpin_fam | 5.08e-03 | 39 | 51 | 2 | IPR000215 | |
| Domain | Laminin_G_2 | 5.34e-03 | 40 | 51 | 2 | PF02210 | |
| Domain | LamG | 6.43e-03 | 44 | 51 | 2 | SM00282 | |
| Domain | Laminin_G | 1.10e-02 | 58 | 51 | 2 | IPR001791 | |
| Domain | BACK | 1.17e-02 | 60 | 51 | 2 | SM00875 | |
| Domain | BACK | 1.21e-02 | 61 | 51 | 2 | PF07707 | |
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 21418859 | ||
| Pubmed | Reduced transcript expression of genes affected by inherited and de novo CNVs in autism. | 1.26e-05 | 4 | 51 | 2 | 21448237 | |
| Pubmed | The cytoplasmic tail of fibrocystin contains a ciliary targeting sequence. | 2.10e-05 | 5 | 51 | 2 | 20048263 | |
| Pubmed | 3.15e-05 | 6 | 51 | 2 | 25103237 | ||
| Pubmed | 3.15e-05 | 6 | 51 | 2 | 16952463 | ||
| Pubmed | 3.15e-05 | 6 | 51 | 2 | 17244818 | ||
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 3.18e-05 | 248 | 51 | 5 | 24006456 | |
| Pubmed | A family of protein-deglutamylating enzymes associated with neurodegeneration. | 4.41e-05 | 7 | 51 | 2 | 21074048 | |
| Pubmed | Arf4 is required for Mammalian development but dispensable for ciliary assembly. | 4.41e-05 | 7 | 51 | 2 | 24586199 | |
| Pubmed | 7.54e-05 | 9 | 51 | 2 | 26829768 | ||
| Pubmed | IL-7Rα glutamylation and activation of transcription factor Sall3 promote group 3 ILC development. | 1.38e-04 | 12 | 51 | 2 | 28794449 | |
| Pubmed | 3.18e-04 | 18 | 51 | 2 | 9090377 | ||
| Pubmed | 3.55e-04 | 19 | 51 | 2 | 20619750 | ||
| Pubmed | Comparative analysis of 1196 orthologous mouse and human full-length mRNA and protein sequences. | 6.19e-04 | 25 | 51 | 2 | 8889551 | |
| Pubmed | Tubby family proteins are adapters for ciliary trafficking of integral membrane proteins. | 6.19e-04 | 25 | 51 | 2 | 28154160 | |
| Pubmed | Klf4 glutamylation is required for cell reprogramming and early embryonic development in mice. | 6.19e-04 | 25 | 51 | 2 | 29593216 | |
| Pubmed | 6.29e-04 | 720 | 51 | 6 | 16381901 | ||
| Pubmed | 6.38e-04 | 722 | 51 | 6 | 15489336 | ||
| Pubmed | 1.04e-03 | 794 | 51 | 6 | 11076863 | ||
| Pubmed | 1.08e-03 | 33 | 51 | 2 | 24204828 | ||
| Pubmed | Early embryonic expression of murine coagulation system components. | 1.15e-03 | 34 | 51 | 2 | 11154109 | |
| Pubmed | 1.27e-03 | 552 | 51 | 5 | 36293380 | ||
| Cytoband | 4q27 | 2.76e-04 | 22 | 51 | 2 | 4q27 | |
| Coexpression | GSE13547_WT_VS_ZFX_KO_BCELL_ANTI_IGM_STIM_12H_DN | 1.31e-05 | 159 | 50 | 5 | M2983 | |
| Coexpression | BOCHKIS_FOXA2_TARGETS | 1.76e-05 | 434 | 50 | 7 | M1806 | |
| Coexpression | BOCHKIS_FOXA2_TARGETS | 2.81e-05 | 467 | 50 | 7 | MM1233 | |
| ToppCell | COPD-Stromal-Pericyte|COPD / Disease state, Lineage and Cell class | 2.41e-06 | 184 | 52 | 5 | a56264a22dfc2d3672b20134ab7c3c7c23da5ae1 | |
| ToppCell | 10x5'v1-week_14-16-Hematopoietic-MK-early_MK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.20e-06 | 195 | 52 | 5 | 9b4f217325afb2efb9c65f298ac87649cb1e1af9 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.28e-06 | 196 | 52 | 5 | 12d9028f90c057c6e5cff00301793fa550e86c5a | |
| ToppCell | Bronchial-10x5prime-Stromal-Pericyte-Muscle_pericyte_pulmonary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.62e-06 | 200 | 52 | 5 | 12326cc6f0af24bacba9493dc79e7c7347db2f41 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.62e-06 | 200 | 52 | 5 | d2fcd3bd7c3223875f027eeb48ff621192a5f242 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Pericyte|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.62e-06 | 200 | 52 | 5 | 4e1e19214aeebbdca004de7faaf4cc9d18498591 | |
| ToppCell | Control_saline-Mesenchymal_myocytic|Control_saline / Treatment groups by lineage, cell group, cell type | 3.62e-06 | 200 | 52 | 5 | 5ed4261157cd51109b314818133ac3a0d34ee5fa | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.62e-06 | 200 | 52 | 5 | 67dcbd86fbc79fd585d0793f979e4aac100326c9 | |
| ToppCell | Bronchial-10x5prime-Stromal-Pericyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.62e-06 | 200 | 52 | 5 | 362706445edb33b313684efe50b1f44f5f816e67 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte|Control_saline / Treatment groups by lineage, cell group, cell type | 3.62e-06 | 200 | 52 | 5 | cb7ef774b6d300f8019c5b16a04e3ebd165e4f1c | |
| ToppCell | Parenchymal-10x5prime-Stromal-Pericyte-Muscle_pericyte_pulmonary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.62e-06 | 200 | 52 | 5 | f9bc22ff17bb1c751e6b05bca3f403836f33459a | |
| ToppCell | Parenchymal-10x5prime-Stromal-Pericyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.62e-06 | 200 | 52 | 5 | 0a7640db28c708003d5da2d19eb651f6fedfd710 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.62e-06 | 200 | 52 | 5 | 77631c471cc5d453a749784f838cfa6408caf09b | |
| ToppCell | facs-Pancreas-Exocrine-24m-Epithelial-pancreatic_D_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.39e-05 | 157 | 52 | 4 | 370f44047ef438b8f1124c2c2761c150c0d8c57f | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.65e-05 | 160 | 52 | 4 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.65e-05 | 160 | 52 | 4 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Neural-neural_cell-Schwann_Cell_/_Neural|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.74e-05 | 161 | 52 | 4 | 7d1bc73f4c82465b3f489d6737048b0cd54f22cf | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Neural-neural_cell-Schwann_Cell_/_Neural-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.74e-05 | 161 | 52 | 4 | 410eef62c83c704cbfc5a1b643c4db11bbdcd81f | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Neural|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.74e-05 | 161 | 52 | 4 | 71022485da6754a2b57b4c3e758e3de4c95cc292 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Neural-neural_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.74e-05 | 161 | 52 | 4 | 59ae8a7c9a04ecaa335b8064852a5a91a21780bd | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-enterocyte_of_epithelium_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.83e-05 | 162 | 52 | 4 | bc63a96ad3ba0b3433e3679d7a005f47709ff384 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-1|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.83e-05 | 162 | 52 | 4 | 56f1789e69a6cb29956e46aba92b290847327c1f | |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D231|Adult / Lineage, Cell type, age group and donor | 4.84e-05 | 172 | 52 | 4 | 858cee96c1c06160863b4adcd7023c0d678bd50f | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.95e-05 | 173 | 52 | 4 | 30d67738633493d47f06ae452424382f069b6c0a | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Epithelial-goblet|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.06e-05 | 174 | 52 | 4 | e7cca4b6a3935fad61cf2a3d9984ab1ffa1a9447 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Epithelial-goblet-Goblet_cell|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.06e-05 | 174 | 52 | 4 | ad5b56f0ace6455c033834b931ec870cc0dc9290 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.18e-05 | 175 | 52 | 4 | bb898796662b97f7459b7dda7cecf6a9bde8b055 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.65e-05 | 179 | 52 | 4 | dc6cd46fa652b296ddbc41855f6377946d0a4cdc | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.77e-05 | 180 | 52 | 4 | f6a05b3751b01e74b2de8440801b0eb2e723c199 | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.77e-05 | 180 | 52 | 4 | dfc75ae4395ff46fbec2c54915d98ead5a1ba1a1 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.16e-05 | 183 | 52 | 4 | 8a799807fbf24456a9811e0c64068187940a2f71 | |
| ToppCell | 10x5'v1-week_12-13-Hematopoietic-MK-MK|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 6.16e-05 | 183 | 52 | 4 | 6cbc88c27dc957d182526e84824f70c8e860bf74 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.29e-05 | 184 | 52 | 4 | 689a8af81a79a4bb3123cfa01958c953eab5de98 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.56e-05 | 186 | 52 | 4 | 6add08d4ca019ff2864acdd5ec2c66a59a574591 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.56e-05 | 186 | 52 | 4 | 888e85a025bd982d36c910db0f5a3385b1ca3b28 | |
| ToppCell | COPD-Stromal-Pericyte|World / Disease state, Lineage and Cell class | 6.56e-05 | 186 | 52 | 4 | 8adfd2d1fda4e8aecc95192ea627bf7ed5214b8d | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 6.69e-05 | 187 | 52 | 4 | a9316e2818217ec5feae9cf8816f7249803caee6 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.83e-05 | 188 | 52 | 4 | 293f2fa99f5f96aa7fd2b2a5cc94ff60eeaabe11 | |
| ToppCell | 10x5'v1-week_17-19-Hematopoietic|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.83e-05 | 188 | 52 | 4 | c00ba0abd0c7bb2c8f9166a2ac6220aae4f4d857 | |
| ToppCell | COPD-Myeloid-cMonocyte|COPD / Disease state, Lineage and Cell class | 6.98e-05 | 189 | 52 | 4 | d29f3a0bd23e6eb46389e6eb7ef21851c7b57545 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.98e-05 | 189 | 52 | 4 | 7ab1cfc1657277858339f7258a0c4ae9cb42fdf8 | |
| ToppCell | IPF-Myeloid-cMonocyte|Myeloid / Disease state, Lineage and Cell class | 6.98e-05 | 189 | 52 | 4 | ad7bb3a7de8e48c145e4382f90d30bb2159c2b76 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.12e-05 | 190 | 52 | 4 | 26843ec1d19ac85a50990705353b802745d33e4d | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 7.12e-05 | 190 | 52 | 4 | 7986586b7c82e91c71102cc8c4d7a689ae63ab4d | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.12e-05 | 190 | 52 | 4 | 63018acb7ad80415e861643162abdc2e55968ee4 | |
| ToppCell | IPF-Myeloid-cMonocyte|IPF / Disease state, Lineage and Cell class | 7.12e-05 | 190 | 52 | 4 | a099f51f2b7618b6712af38eedd5ee64d8663a4a | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.12e-05 | 190 | 52 | 4 | 0fea33f2dc1efa23aaa2da1c318482a52a313ff1 | |
| ToppCell | 10x3'2.3-week_17-19-Hematopoietic-MK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 7.12e-05 | 190 | 52 | 4 | 64060e4b56ac9989e659c2d5d2a6b6edeba4d8d4 | |
| ToppCell | facs-Lung-3m-Mesenchymal-myofibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.27e-05 | 191 | 52 | 4 | fd8331c7abdd999f55ba43d307945c6abfccbf84 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.27e-05 | 191 | 52 | 4 | 7853ac7dff649150e6ff27cd4c8cf7c1fc034ed4 | |
| ToppCell | 10x5'v1-week_14-16-Hematopoietic-MK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 7.27e-05 | 191 | 52 | 4 | 7edc22e7e70697fb22690699efb352577162709b | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.41e-05 | 192 | 52 | 4 | 992d08092edbc68c47b945deb8708379738c239a | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.41e-05 | 192 | 52 | 4 | 6bba80887d6f64cf913a5c22f62baaddda417ce0 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.41e-05 | 192 | 52 | 4 | 9946f5d5cab64936ca68d9f4dc9ce6eba85b43ab | |
| ToppCell | 10x3'2.3-week_12-13-Hematopoietic-MK-MK|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 7.56e-05 | 193 | 52 | 4 | 3d4411b3c1cb160dec5db29f0c126d8827dfe185 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.72e-05 | 194 | 52 | 4 | 8f19e553f18c313c2a2ff9453884b9484b255d71 | |
| ToppCell | 10x5'v1-week_12-13-Hematopoietic-MK|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 7.72e-05 | 194 | 52 | 4 | 245a3eb6db9c862b73ad34a8cd2898a3688c16f6 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.72e-05 | 194 | 52 | 4 | 67fbb81b7d20cb63be27b2a2beea5b5689f8e08c | |
| ToppCell | 390C-Myeloid-Dendritic-cDC2|390C / Donor, Lineage, Cell class and subclass (all cells) | 7.72e-05 | 194 | 52 | 4 | 705fa653c11b6c8a427e007533aa4a4bb5845078 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.72e-05 | 194 | 52 | 4 | f95935153bd2c4c3c7b2b729da6f7e98b45fed79 | |
| ToppCell | COVID-19-lung-Pericytes/_Smooth_Muscle|lung / Disease (COVID-19 only), tissue and cell type | 7.72e-05 | 194 | 52 | 4 | 5e1e0513a54ec4cf0b247ec85c9fbc68dfac1da3 | |
| ToppCell | facs-Lung-3m-Mesenchymal-myofibroblast-myofibroblast_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.87e-05 | 195 | 52 | 4 | c6bb16c0076639c6ddef1a15d8cba44bc29c077d | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Mesenchymal-Myofibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.87e-05 | 195 | 52 | 4 | 3f64e2313ec79a6d5f4013a52722d071172f6c5d | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Neuronal-Glial_immature|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.87e-05 | 195 | 52 | 4 | 9fea1ddb68da83ca43dd8006c9e51295b1817f0e | |
| ToppCell | facs-Lung-3m-Mesenchymal-myofibroblast-myofibroblast_cell-pulmonary_interstitial_myofibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.87e-05 | 195 | 52 | 4 | ea89f80d3d7e9f737442f7c1aa1791d277ffc90c | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Mesenchymal-pulmonary_interstitial_fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.87e-05 | 195 | 52 | 4 | 7a5108335353ac160b684650c5da97d6f7f4dbcf | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.03e-05 | 196 | 52 | 4 | 9afd0a7135028a446f06bb68f334e79b8f171b45 | |
| ToppCell | COVID-19-lung-Pericytes/_Smooth_Muscle|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.03e-05 | 196 | 52 | 4 | 754a3613340932563cd8424d775e18b93c3a1aaa | |
| ToppCell | Transverse-T_cell-Treg|T_cell / Region, Cell class and subclass | 8.19e-05 | 197 | 52 | 4 | b7a1637e4baadd657f6279f4aa96cd590c9cd8c9 | |
| ToppCell | Fibroblast|World / shred by cell class for bronchial biopsy | 8.19e-05 | 197 | 52 | 4 | 8bf9846228b6b6721b10375fe54a2fb389ff64a6 | |
| ToppCell | Bronchus_Control_(B.)|World / Sample group, Lineage and Cell type | 8.19e-05 | 197 | 52 | 4 | b6dff2ee108813e18657e2d8cf850e2423f8c8e9 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.19e-05 | 197 | 52 | 4 | 43b5f8e917506c1717f9311584901b506ffd2c79 | |
| ToppCell | Fetal_29-31_weeks|World / Lineage, Cell type, age group and donor | 8.51e-05 | 199 | 52 | 4 | 5b9d355795dd03a22f0961dfd143425c367a4654 | |
| ToppCell | Transverse-T_cell-Treg|Transverse / Region, Cell class and subclass | 8.51e-05 | 199 | 52 | 4 | 5a483208fbd205a6aac443c22179742806942934 | |
| ToppCell | Transverse-(1)_T_cell-(15)_Treg|Transverse / shred on region, Cell_type, and subtype | 8.51e-05 | 199 | 52 | 4 | 807a6dd05c4112ce7c62ed9f37bb02b783c60bc7 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 8.68e-05 | 200 | 52 | 4 | b5b5a32925f225610fe25a021a742d6397162863 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Smooth_muscle-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 8.68e-05 | 200 | 52 | 4 | 0c648941447c738caf62f2d71e296d6cca492c8b | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 8.68e-05 | 200 | 52 | 4 | f599e4b051ac3dad11ad437e98dc8ea6754cca53 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Pericyte|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 8.68e-05 | 200 | 52 | 4 | b22cae282591d8dead9869c2adbb9632615f50f7 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-CHRM2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 8.68e-05 | 200 | 52 | 4 | 501a3b93624df463458a35d3e6648d4ccc941724 | |
| ToppCell | Parenchyma_COVID-19-Stromal-TX-Smooth_muscle-1|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 8.68e-05 | 200 | 52 | 4 | 78e9a40153d7ba5d9ea6393a37d26fc5c0220867 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-CHRM2-L1-3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 8.68e-05 | 200 | 52 | 4 | d1f36a8232411933b1494168ec912fd0e5246428 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.68e-05 | 200 | 52 | 4 | 522a51a284d2992d519c4669e1a48c8ebcc08c80 | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Smooth_muscle-1|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.68e-05 | 200 | 52 | 4 | c46e06b4f22d3456e67bc62a9ac198e8041965ad | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Smooth_muscle-1-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.68e-05 | 200 | 52 | 4 | 43b76e382b38b9856c07557a75e5b1ce0cee1d9e | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 8.68e-05 | 200 | 52 | 4 | 786f1ae53e60b5ffbf4bfd393d10b802478148b3 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.68e-05 | 200 | 52 | 4 | 94f1fa61aa82eb9f411b2b1cb759476939ab5db7 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte-Pericyte_2|Control_saline / Treatment groups by lineage, cell group, cell type | 8.68e-05 | 200 | 52 | 4 | bc8949eb34482aca166c4602ff6ab876cb4c2c3c | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-interstitial_macrophage-interstitial_macrophage_l14|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.58e-04 | 106 | 52 | 3 | ede8407ad253080d1fa2a6e2aacf549ce220309a | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_dendritic-CD141-positive_myeloid_dendritic_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.13e-04 | 134 | 52 | 3 | 0b1bb6fee8a2d8c27bca6d9cac6b47e85073dbf7 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_PT|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.13e-04 | 134 | 52 | 3 | cb676d5bbc468bd3ce1b6712d41c986ee9221ac5 | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_2|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 5.24e-04 | 135 | 52 | 3 | 4451c44f3ad788437f4e2ae81049fbbab53f967e | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_2|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 5.24e-04 | 135 | 52 | 3 | 45f67f33c8320d9fb6dbceae603b564f6a8ffd1e | |
| ToppCell | LPS-antiTNF-Myeloid-Myeloid_granulocytic|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.20e-04 | 143 | 52 | 3 | 4a0f26eef935fe68a1da5d319503059a8a8682dd | |
| ToppCell | LPS-antiTNF-Myeloid-Myeloid_granulocytic-Neutrophils|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.20e-04 | 143 | 52 | 3 | 65328a0a2f3972fac596e07933e74b2ef7cceb84 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 6.33e-04 | 144 | 52 | 3 | 1c001a5a3bbe4ecbce8305f8b260e933033550dd | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage_3|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 6.33e-04 | 144 | 52 | 3 | 5e948d4cb913ccd8f82262a1b4d20967aadab3ab | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Crispld2_Htr2c|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.58e-04 | 146 | 52 | 3 | 47368f981180ca6a8c81a50f7f9430f12456f609 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.85e-04 | 148 | 52 | 3 | f85dc34f6a4a15ecffa4fbd5644dea12ce30089b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.85e-04 | 148 | 52 | 3 | 4b1fdf90c585f89cee1cf521db4e3fafc9d74d9a | |
| Disease | hemoglobin measurement, hemoglobin A2 measurement | 2.80e-05 | 5 | 50 | 2 | EFO_0004509, EFO_0005845 | |
| Disease | hemoglobin E disease | 4.20e-05 | 6 | 50 | 2 | MONDO_0016243 | |
| Disease | level of Phosphatidylethanolamine (18:1_18:1) in blood serum | 2.53e-04 | 14 | 50 | 2 | OBA_2045142 | |
| Disease | Malignant neoplasm of breast | 4.14e-04 | 1074 | 50 | 8 | C0006142 | |
| Disease | Colorectal Carcinoma | 1.16e-03 | 702 | 50 | 6 | C0009402 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GVLAVNGCAVVFQYM | 776 | Q6QNK2 | |
| GMTEVQCGKVAFQFQ | 501 | Q96KE9 | |
| QGEAGQKCMVGYVNA | 811 | Q32M45 | |
| IINCEKSNSQFNYGM | 766 | Q9UPW5 | |
| TQCSQFLYGVQEKMG | 1041 | Q13625 | |
| INCEKPNSQFNYGMQ | 651 | Q96MI9 | |
| KQYVNEAFQAGAMTC | 146 | Q6ZNB6 | |
| GQMCFQIGQAKNTYG | 266 | Q14409 | |
| CYKIQNFNNVIPEGM | 181 | Q9NPH3 | |
| INFYAGANQSMNVTC | 186 | P14415 | |
| LGGNMKKIENCNYAV | 451 | Q14651 | |
| VIFCGLGIQNTQMYE | 496 | O76074 | |
| MQEQKNEGCQVYGFL | 191 | Q9Y282 | |
| GDFMCKFVNYIQQVS | 111 | Q969F8 | |
| QDQQGPFKMCLNYEV | 3301 | P98088 | |
| QDQQGPFKMCLNYEV | 4706 | P98088 | |
| CGNFKVNAIYGLMVA | 191 | Q8NGI0 | |
| QQTSGMFLFGIQNNC | 1441 | O94916 | |
| CGEQNMINFAPNIYI | 921 | Q6YHK3 | |
| VMPNLYGNIVNNVCA | 271 | P51553 | |
| QKSCSQIFNYLGRQM | 316 | P51685 | |
| YNLHQKNGFTCMLIG | 51 | Q7Z3C6 | |
| VGQMCFQIGQAKNTY | 271 | P32189 | |
| GEEIACTQNGQMYLN | 36 | P05997 | |
| LQGQNFFLQEFGKMC | 351 | Q9NTJ4 | |
| KNFKGCMESINYNGV | 331 | Q9UHC6 | |
| QMQAAYQKVVAGVAN | 126 | P02042 | |
| GQVVMLYINCKVNGH | 231 | Q5TDH0 | |
| TNNVFEVGCYSQAMK | 86 | O00399 | |
| GEKMQEQQQAAYCVI | 301 | Q13183 | |
| QLVQMNYVGNGTVFF | 251 | P08185 | |
| GGQMKIKNQYLITNC | 391 | Q3ZCT8 | |
| FTSCGFMQQIQKGSY | 76 | P05120 | |
| QINSVFNKYCVNMQG | 541 | Q68CQ4 | |
| FNKYCVNMQGQVAVR | 546 | Q68CQ4 | |
| DIGIQCINAGENMKY | 181 | Q5QGS0 | |
| QVYFGQLLGMCDQIS | 521 | O43272 | |
| LQQECEQLQKMYGGQ | 651 | Q9Y2K2 | |
| SLMQVGGYNNQAKTC | 1771 | Q9C0D5 | |
| YQFLMQGFICKQTDQ | 3396 | P08F94 | |
| FGNCNGIAMVDYLQK | 646 | Q5T5C0 | |
| PVNAFYNGCMEVNIN | 631 | P07225 | |
| YNGCMEVNINGVQLD | 636 | P07225 | |
| GQQKLYEMVSYCQNI | 436 | P46063 | |
| GSMVGVYNGKTFNQV | 91 | P62841 | |
| GCQDNVGAMVVYLNI | 1021 | Q6ZVD8 | |
| TVKANQEMYAIGFCN | 411 | P50443 | |
| CKNYNDLQIAGGQVM | 121 | Q9HAI6 | |
| SVNPNCYAKVVMVNG | 691 | Q92800 | |
| DQGIYQCMAKNVAGE | 311 | Q92626 | |
| NGFCIIENFKGFTMQ | 196 | P12271 | |
| KGYNFGNELTQNMAV | 1261 | Q86WI1 | |
| QNMAVYVGGKTCQIL | 1271 | Q86WI1 | |
| QCQNLTLYQGFCAMK | 491 | Q68DK2 | |
| KTLNVNCVDYMGQNA | 51 | Q13507 | |
| NNNICGVGVAYNSKV | 221 | P16519 |